Andreas Halvorsen's ORKA Position Overview
Andreas Halvorsen (via Viking Global Investors Lp) currently holds 2.67 M shares of Oruka Therapeutics, Inc. (ORKA) worth $130.8 M, representing 0.37% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Andreas Halvorsen has maintained this position in ORKA for several quarters, showing initial confidence in the investment.
Analysis based on 13F filings available since 2013 Q2
Andreas Halvorsen's Oruka Therapeutics (ORKA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Oruka Therapeutics (ORKA) Trades by Andreas Halvorsen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +2.67 M | New Buy | 2.67 M | $19.23 |
Andreas Halvorsen's Oruka Therapeutics Investment FAQs
Andreas Halvorsen first purchased Oruka Therapeutics, Inc. (ORKA) in Q3 2025, acquiring 2,666,690 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen has held Oruka Therapeutics, Inc. (ORKA) for 3 quarters since Q3 2025.
Andreas Halvorsen's largest addition to Oruka Therapeutics, Inc. (ORKA) was in Q3 2025, adding 2,666,690 shares worth $51.28 M.
According to the latest 13F filing for Q1 2026, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 2,666,690 shares of Oruka Therapeutics, Inc. (ORKA), valued at approximately $130.8 M.
As of the Q1 2026 filing, Oruka Therapeutics, Inc. (ORKA) represents approximately 0.37% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings.
Andreas Halvorsen's peak holding in Oruka Therapeutics, Inc. (ORKA) was 2,666,690 shares, as reported at the end of Q3 2025.